Quarterly shows that the company is still cashed up (maybe some were hesitant that a CR was due)
Also, expecting a fair bit of news flow in the coming weeks regarding results of current programs
Another factor i believe is that ESS is mainly held by retail. Retail are the biggest panic sellers. Once the Scoping Study (SS) is done we should have some institutional investors onboard which will also help
- Forums
- ASX - By Stock
- ESS
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-11
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ESS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online